PROGNOSTIC IMPACT OF SERUM CXC CHEMOKINE LIGANDS 4 AND 7 ON MYELODYSPLASTIC SYNDROMES POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT

by DHAKAL, BINOD, WANG, TAO, HAAGENSON, MICHAEL, ZHU, FENLU, TAYLOR, CAROLYN, FENLU, SPELLMAN, STEPHEN R., VERNERIS, MICHAEL R., HSU, KATHARINE, FLEISCHHAUER, KATHARINA, LEE, STEPHANIE J., BOLON, YUNG-TSI, CARLSON, KAREN-SUE, NAZHA, AZIZ, SABER, WAEL
Published in Leuk Lymphoma (2020)

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease

by Drobyski, William R., Szabo, Aniko, Zhu, Fenlu, Keever-Taylor, Carolyn, Hebert, Kyle M., Dunn, Renee, Yim, Sharon, Johnson, Bryon, D’Souza, Anita, Eapen, Mary, Fenske, Timothy S., Hari, Parameswaran, Hamadani, Mehdi, Horowitz, Mary M., Rizzo, J. Douglas, Saber, Wael, Shah, Nirav, Shaw, Bronwen, Pasquini, Marcelo
Published in Haematologica (2018)

A colitogenic memory CD4(+) T cell population mediates gastrointestinal graft-versus-host disease

by Zhou, Vivian, Agle, Kimberle, Chen, Xiao, Beres, Amy, Komorowski, Richard, Belle, Ludovic, Taylor, Carolyn, Zhu, Fenlu, Haribhai, Dipica, Williams, Calvin B., Verbsky, James, Blumenschein, Wendy, Sadekova, Svetlana, Bowman, Eddie, Ballantyne, Christie, Weaver, Casey, Serody, David A., Vincent, Benjamin, Serody, Jonathan, Cua, Daniel J., Drobyski, William R.
Published in J Clin Invest (2016)

Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation

by Chhabra, Saurabh, Visotcky, Alexis, Pasquini, Marcelo C., Zhu, Fenlu, Tang, Xiaoying, Zhang, Mei-Jie, Thompson, Robert, Abedin, Sameem, D’Souza, Anita, Dhakal, Binod, Drobyski, William R., Fenske, Timothy S., Jerkins, James H., Rizzo, J. Douglas, Runaas, Lyndsey, Saber, Wael, Shah, Nirav N., Shaw, Bronwen E., Horowitz, Mary M., Hari, Parameswaran N., Hamadani, Mehdi
Published in Biol Blood Marrow Transplant (2020)